TY  -  
T1  - Prophylactic, preemptive, and curative treatment for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients : a position statement from an international expert group 
SN  -  /  
UR  - http://hdl.handle.net/10138/313991 
T3  -  
A1  - Mohty, Mohamad; Malard, Florent; Abecasis, Manuel; Aerts, Erik; Alaskar, Ahmed S.; Aljurf, Mahmoud; Arat, Mutlu; Bader, Peter; Baron, Frederic; Basak, Grzegorz; Bazarbachi, Ali; Blaise, Didier; Ciceri, Fabio; Corbacioglu, Selim; Dalle, Jean-Hugues; Dignan, Fiona; Fukuda, Takahiro; Huynh, Anne; Kuball, Jurgen; Lachance, Silvy; Lazarus, Hillard; Masszi, Tamas; Michallet, Mauricette; Nagler, Arnon; NiChonghaile, Mairead; Okamoto, Shinichiro; Pagliuca, Antonio; Peters, Christina; Petersen, Finn B.; Richardson, Paul G.; Ruutu, Tapani; Saber, Wael; Savani, Bipin N.; Soiffer, Robert; Styczynski, Jan; Wallhult, Elisabeth; Yakoub-Agha, Ibrahim; Duarte, Rafael F.; Carreras, Enric 
A2  -  
PB  -  
Y1  - 2020 
LA  - eng 
AB  - Sinusoidal obstruction syndrome, also known as veno-occlusive disease (SOS/VOD), is a potentially life-threatening complication that can develop after hematopoietic cell transplantation (HCT). While SOS/VOD may resolve within a few weeks in the majority of patients with mild-to-moderate disease, the most severe forms result in multiorgan dysfunction and are associated with a high mortality rate (>80%). Therefore, careful surveillance may allow early detection of SOS/VOD, particularly as the lice... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - HEPATIC VENOOCCLUSIVE DISEASE; STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; HAPLOIDENTICAL DONOR TRANSPLANTATION; REGIMEN-RELATED TOXICITIES; URSODEOXYCHOLIC ACID; PERIPHERAL-BLOOD; EUROPEAN-SOCIETY; RANDOMIZED-TRIAL; PD-1 BLOCKADE; 3122 Cancers 
N1  -   
PP  -  
ER  -